AIG
CMPI

American International Group’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

American International Group’s Portfolio CMPI Stock Details CMPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,217
Closed -$63 – 3360
2021
Q1 		$63 Buy
5,217
+2,282
+78% +$32.4K ﹤0.01% 2924
2020
Q4 		$43 Sell
2,935
-84
-3% -$1.07K ﹤0.01% 2994
2020
Q3 		$35K Buy
+3,019
New +$38.7K ﹤0.01% 2981

Other funds holding CMPI

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

American International Group's CMPI Position: Q2 2021 in Review

American International Group sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2021, closing a stake of 5,217 shares — an estimated $63 sold.

American International Group first reported a position in CMPI in Q3 2020 and held it in 3 quarters. The position peaked at $35K in Q3 2020. 34 funds tracked by Wall St. Rank hold CMPI as of Q2 2021.

  • American International Group reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 5,217 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $63.
  • American International Group first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • American International Group's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $35K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.